{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:31:18Z","timestamp":1777501878886,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cpcardiol.2023.101586","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T02:27:14Z","timestamp":1672972034000},"page":"101586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and Safety of Vericiguat for Treatment of Heart Failure: A Systematic Review"],"prefix":"10.1016","volume":"48","author":[{"given":"Taha Gul","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizra","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab Syyeda","family":"Rahmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Hassan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summaiyya","family":"Waseem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-2030","authenticated-orcid":false,"given":"Muhammad Sohaib","family":"Asghar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101586_bib0001","article-title":"Global epidemiology and future trends of heart failure","volume":"5","author":"Lippi","year":"2020","journal-title":"AME Med J [Internet]."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0002","series-title":"Comprehensive Physiology [Internet]","first-page":"187","article-title":"Pathophysiology of heart failure","author":"Tanai","year":"2015"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0003","unstructured":"Safety and efficacy of soluble guanylate cyclase stimulators in patients with heart failure: a systematic review and meta-analysis [Internet]. [cited 2022 Nov 18]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7596421\/#B2."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0004","unstructured":"FDA approves vericiguat for reducing cardiovascular death and heart failure [internet]. [cited 2022 Nov 18]. Available from: https:\/\/www.uspharmacist.com\/article\/fda-approves-vericiguat-for-reducing-cardiovascular-death-and-heart-failure."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA [Internet]"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0006","unstructured":"The efficacy and safety of soluble guanylate cyclase stimulators in patients with heart failure [Internet]. 2022 [cited Nov 18]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6203591\/."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0007","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/ejhf.2221","article-title":"Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (vericiguat global study in subjects with HFrEF) trial","volume":"23","author":"Voors","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0008","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions Cochrane Training [Internet]. 2022 [cited Nov 18]. Available from: https:\/\/training.cochrane.org\/handbook#how-to-access."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0009","unstructured":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews - PubMed [Internet]. [cited 2022 Nov 18]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33782057\/."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0010","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the soluble guanylate cyclase stimulatoR in heart failure patients with preserved EF (SOCRATES-preserved) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0012","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-reduced randomized trial","volume":"314","author":"Gheorghiade","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0013","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ejhf.2285","article-title":"Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial","volume":"23","author":"Ponikowski","year":"2021","journal-title":"Eur J Heart Fail [Internet]"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0014","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jchf.2020.08.008","article-title":"N-terminal pro-B-type natriuretic peptide and clinical outcomes: vericiguat heart failure with reduced ejection fraction study","volume":"8","author":"Ezekowitz","year":"2020","journal-title":"JACC Heart Fail [Internet]"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamacardio.2020.6455","article-title":"Clinical outcomes and response to vericiguat according to index heart failure event: insights from the VICTORIA trial","volume":"6","author":"Lam","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0016","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the vitality-HFPEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0017","first-page":"1067","volume":"35","author":"Aimo","year":"2021"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0018","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/eurheartj\/ehv132","article-title":"Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction","volume":"36","author":"Lim","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0019","first-page":"225","article-title":"Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure. In: Bauersachs J, Butler J, Sandner P, editors","author":"Breitenstein","year":"2017","journal-title":"Heart Failure. Cham: Springer International Publishing"},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0020","unstructured":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease [internet].2022 [cited Nov 19]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3103045\/."},{"key":"10.1016\/j.cpcardiol.2023.101586_bib0021","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-Terminal-Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:02:45Z","timestamp":1758938565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0146280623000038"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101586","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Vericiguat for Treatment of Heart Failure: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101586"}}